Blood test may predict catatonia drug response
NCT ID NCT04530734
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at 100 adults with catatonia, a severe movement and mood disorder. Researchers want to see if the amount of lorazepam in the blood after 3 days of treatment can predict who will get better. They also check if certain genes affect how the body processes the drug, which could help doctors adjust treatment sooner.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CATATONIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hôpital Fontan, CHU lille
RECRUITINGLille, 59037, France
Contact Phone: •••-•••-••••
Contact